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Abstract It has been reported that in rat fibroblasts cell-perme- 
able ceramide analogs inhibit agonist-indnced phospholipase D 
(PLD)-mediated hydrolysis of phosphatidylcholine (PtdCho). 
Here we demonstrate that relatively short (30 rain) treatments of 
NIH 3T3 fibroblasts with 15-60/tM concentrations of N-ace- 
tylsphingosine result in preferential, although not exclusive, inhi- 
bition of phorhol 12-myristate 13-acetate-induced PLD-mediated 
hydrolysis of phosphatidylethanolamine (PtdEtn). The results 
suggest that in different cell types the PtdEtn- and PtdCho- 
hydrolyzing PLD activities are differentially sensitive to the in- 
hibitory effect of ceramide. 
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1. Introduction 
It has recently been reported [1] that in rat fibroblasts the 
cell-permeable ceramide analog N-acetylsphingosine (C~- 
ceramide) can inhibit phospholipase D (PLD)-mediated hy- 
drolysis of phosphatidylcholine (PtdCho). Since this report ap- 
peared, several other laboratories also described, using other 
cell lines, inhibition of agonist-stimulated PLD activity by cer- 
amide, except hat in these latter studies the nature of phospho- 
lipid substrate was not identified [24]. 
In NIH 3T3 fibroblasts, activation of the PLD system(s) by 
the protein kinase C (PKC) activator phorbol 12-myristate 
13-acetate (PMA) [5], sphingosine [6], nucleotides [6] and sev- 
eral hormones [7] were found to result in significant hydrolysis 
of both PtdCho and phosphatidylethanolamine (PtdEtn). Nev- 
ertheless, in many respects the regulation of PtdCho and 
PtdEtn hydrolysis in fibroblasts appears to be different, sug- 
gesting that these phospholipids may play different roles in 
signal transduction (reviewed in [8,9]). Importantly, PLD-medi- 
ated hydrolysis of PtdEtn has also been observed in several 
other cell lines [10-15], and in some cases only PtdEtn was 
hydrolyzed by activated PLD [16]. For these reasons, it may 
become important to identify the substrate(s) of the ceramide- 
inhibitable PLD system(s). Here we report that in NIH 3T3 
fibroblasts C2-ceramide preferentially, although not exclu- 
sively, inhibits PMA-induced PtdEtn hydrolysis. 
2. Materials and methods 
2.1. Materials 
C2-ceramide was purchased from Matreya Inc.; it was delivered to 
fibroblasts in a 1 : 1 complex with fatty acid-free bovine serum albumin. 
PMA, SMase (from Staphylococcus aureus), and Dowex-50W[H ÷form] 
were from Sigma; [2J4C]ethanolamine (60 mCi/mmol), [methyl- 
~4C]choline chloride (55 mCi/mmol), and [1-~4C]palmitic acid (60 mCi/ 
mmol) were from Amersham; tissue culture reagents were from Gibco 
BRL. Phosphatidylethanol (PtdEtOH) was from Avanti Polar Lipids 
Inc. 
2.2. Cell culture 
NIH 3T3 clone 7 fibroblasts were obtained from Dr. Douglas R. 
Lowy (National Cancer Institute, Bethesda, MD) and were cultured 
continuously in Dulbecco's Modified Eagle's Medium supplemented 
with 10% (v/v) fetal calf serum, penicillin (50 units/ml), streptomycin 
(50/lg/ml) and glutamine (2 mM). 
2.3. Measurement of formation of PtdEtOH in N1H 3T3 fibroblasts 
prelabeled with [14 C]palmitic acid 
Fibroblasts were grown in 6-well tissue culture dishes for 48 h to 
about 90% confluency, and labeled with [l-~4C]palmitic a id (0.35/iCi/ 
ml) for the last 24 h. The attached fibroblasts were washed, incubated 
in fresh Dulbecco's medium for an additional 2 h (to minimize the 
amount of unesterified labeled palmitic acid), and then treated with 100 
nM PMA and/or 60/IM C2-ceramide, or SMase (200 mU/ml), in the 
presence of 200 mM ethanol as indicated in Fig. 1. Incubations were 
performed in an incubator at 37°C and were terminated by scraping the 
fibroblasts into 2 ml of ice-cold methanol followed by rapid transfer of 
the methanol extract o 2 ml of chloroform. PtdEtOH was separated 
from other phospholipids on potassium oxalate (1%)-impregnated sil- 
ica gel H plates (Analtech) by using the solvent system of chloroform/ 
methanol/acetone/acetic acid/water (50: 10: 15 : 10: 2, by vol). 
2.4. Determination of water-soluble products of phospholipid hydrolysis 
in N1H 3 T3 fibroblasts 
Fibroblasts, eeded (2 x 105/dish) in 150 mm-diameter plastic dishes, 
were incubated with either [methyl-~ac]choline (0.35 HCi/ml) or [2- 
~4C]ethanolamine (0.25 HCi/ml) for 60 h, washed, then incubated in 
fresh medium for 3.5 h (to decrease the cellular level of water-soluble 
~4C-labeled precursors [17]. Fibroblasts were harvested by scraping 
from 3-6 dishes. After an additional 20 min incubation period (required 
for the slightly increased 1,2-diacylglycerol level to return to normal 
level [18]), fibroblasts were pelleted for 8 min at 500 x g. Resuspended 
fibroblasts were incubated (final vol. 0.25 ml; 1.8-2.2 × 10 6 cells/ml) in 
the presence of 2 mM ethanolamine or 20 mM choline, as appropriate, 
to prevent phosphorylation f newly formed [~4C]ethanolamine a d 
[~4C]choline [5]. Incubations were terminated by addition of 4 ml of 
chloroform/methanol (1:1, v/v). Separation of ethanolamine and 
choline metabolites was performed on Dowex-50(H+)-packed columns 
as described earlier [17,19]. Phospholipids were separated as in [20]. 
*Corresponding author. Fax: (1) (507) 437-9606. 
Abbreviations: PLD, phospholipase D; PtdCho, phosphatidylcholine; 
PtdEtn, phosphatidylethanolamine; PMA, phorbol 12-myristate 13- 
acetate; C2-ceramide, N-acetylsphingosine; PtdEtOH, phosphatidyle- 
thanol; SMase, sphingomyelinase. 
3. Results and discussion 
In a previous study [19], we determined that treatments of 
NIH 3T3 fibroblasts with 200-400 mU/ml of bacterial SMase 
for 20-30 min was sufficient o degrade the entire cell surface 
pool of sphingomyelin (about 50% of the total cellular pool of 
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Fig. 1. Effects of SMase and C2-ceramide on the formation of 
['4C]PtdEtOH in [14C]palmitic a id-labeled NIH 3T3 fibroblasts. NIH 
3T3 fibroblasts, prelabeled with [14C]palmitic a id for 24 h as described 
in section 2, were incubated for 30 min in the absence (I) or presence 
(II) of 100 nM PMA with the incubation medium containing no other 
addition (~) or containing 200 mU/ml of SMase (~) or 60 pM C2- 
ceramide (I); SMase and C2-ceramide were added to the medium 5 min 
prior to the addition of PMA. Data are the mean + S.E.M. of three 
incubations. Similar esults were obtained in another experiment. 
sphingomyelin) and that during this process only ceramide, but 
not sphingosine, was formed. We also found that at a density 
of 2 x 106 cells/ml, the highest concentration of C2-ceramide 
with no significant cytotoxic effects over a 30-min incubation 
period was 60 pM. Thus, first we examined the effects of 200 
mU/ml of SMase and 60/.tM C2-ceramide on the synthesis of 
PtdEtOH, which is a specific function of PLD [21,22], in 
[~4C]palmitic acid-labeled NIH 3T3 fibroblasts during a 30-min 
incubation period. In the absence of PMA, cells synthesized 
only small amounts of [~4C]PtdEtOH; this was not affected by 
either SMase or C2-ceramide (Fig. 1; I). Addition of 100 nM 
PMA greatly enhanced the formation of [14C]PtdEtOH; this 
PMA effect was similarly (23-33%) inhibited by SMase and 
C2-ceramide (Fig. 1, II). Although these data confirmed previ- 
ous data [14] that ceramide can inhibit PMA-induced PLD 
activity, under the present conditions the effect of ceramide was 
clearly less than that reported by others using different cell 
types and different incubation procedures. 
In [14C]palmitic acid labeled fibroblasts the ratio of ~4C activ- 
ity in PtdCho and PtdEtn was 3.6:1. Preferential labeling of 
PtdCho if accompanied by only small effects of ceramide on 
PtdCho hydrolysis could clearly mask a major effect of cer- 
amide on PtdEtn hydrolysis. Therefore, characterization f the 
actions of ceramide required separate analysis of PtdCho and 
PtdEtn hydrolysis. Previously, we determined that in 
[lac]choline- and [14C]ethanolamine-labeled NIH 3T3 fibro- 
blasts the activators of PKC and several other agents as well 
stimulate the formation of [lac]choline and [14C]ethanolamine 
through PLD-mediated hydrolysis of the respective labeled cel- 
lular phospholipids [5-7]. Thus, in the following experiments 
we examined the effects of the cell-permeable c ramide analog, 
C2-ceramide, on PLD-mediated hydrolysis of PtdCho and 
PtdEtn in [~4C]choline- and [14C]ethanolamine-labeled fibro- 
blasts, respectively. Only C2-ceramide was used because com-  
mercial SMase preparations contained significant phospholip- 
ase C activity, making interpretation of data difficult. 
Treatment of [14C]ethanolamine-labeled fibroblasts for 30 
min with increasing concentrations of C2-ceramide resulted in 
progressive inhibition of PMA-induced [14C]PtdEtn hydrolysis; 
at the highest concentration (60 /~M) tested, C2-ceramide 
caused 55% inhibition of this PMA effect (Fig. 2A). In the 
absence of PMA, C2-ceramide had no effect on the formation 
of [~4C]ethanolamine (Fig. 2A). Surprisingly, treatment of 
[~4C]choline-labeled fibroblasts with even 60/~M C2-ceramide 
inhibited PMA-induced PtdCho hydrolysis only by 27% (Fig. 
2B). 
Recent evidence strongly indicate that the stimulatory effects 
of PMA on the hydrolysis of both PtdCho [4,23-25] and PtdEtn 
[16] are mediated by PKC-~. Furthermore, ceramide has been 
shown to inhibit PLD activity by preventing translocation of 
PKC-~z to the membrane fraction [4]. Therefore, the observed 
differences in ceramide ffects on the hydrolysis of PtdCho and 
PtdEtn can occur only if regulation of these hydrolytic proc- 
esses by PKC-~ involves, at least in part, different mechanisms. 
Since PKC is known to regulate PtdCho hydrolysis by both 
phosphorylation-dependent [26] and -independent [27] mecha- 
nisms, it seemed possible that these mechanisms play different 
roles in the regulation of PtdCho and PtdEtn hydrolysis. To 
examine this possibility, we determined the effects of bisin- 
dolylmaleimide GF 109203X, a potent and selective inhibitor 
of PKC-mediated protein phosphorylation [28], on the hydrol- 
ysis of these phospholipids. Surprisingly, even very high con- 
centrations (25-75 /IM) of GF 109203X inhibited PMA- 
induced PtdCho hydrolysis only by about 50% when the incu- 
bation time was 30 min (Fig. 3A). In contrast, these concentra- 
tions of GF 109203X almost completely inhibited PMA- 
induced PtdEtn hydrolysis (Fig. 3B). These data suggest hat 
at this time point, the action of PMA on PtdCho hydrolysis 
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Fig. 2. Concentration-dependent effects of C2-ceramide on the hydrol- 
ysis of PtdEtn and PtdCho in NIH 3T3 fibroblasts. NIH 3T3 fibroblasts 
were labeled with [14C]ethanolamine (A) or []4C]choline (B) for 60 h, 
followed by treatment of labeled fibroblasts for 30 min with different 
concentrations ofC2-ceramide (15-60/.tM) in the absence (o) or pres- 
ence (~,) of 100 nM PMA. C2-ceramide was added to the medium 5 min 
prior to the addition of PMA. Each point represents he mean + S.E.M. 
of six independent incubations. Similar results were obtained in three 
other experiments (each performed in triplicate) using 20 min incuba- 
tion time. *Significantly (P < 0.01) different from the value obtained 
with PMA alone. 
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Fig. 3. Inhibition of PMA-induced hydrolysis of [~4C]PtdCho and 
[~4C]PtdEtn by GF 109203X in NIH 3T3 fibroblasts. NIH 3T3 fibro- 
blasts were labeled with ['4C]choline (A) or [14C]ethanolamine (B) for 
60 h, followed by pretreatments of suspended fibroblasts with varying 
concentrations (0.1-75 /~M) of GF 109203X for 15 min. This was 
followed by treatments with GF 109203X for another 30 min in the 
absence (e) or presence of 100 nM PMA (A). Each point represents he 
mean + S.E.M. of two experiments each performed in quadruplicate. 
involved both phosphorylating and non-phosphorylating 
mechanisms. We should note here that after 60 min treatment, 
25/zM GF  109203X caused about 80% inhibition of PMA- 
induced PtdCho hydrolysis, indicating that upon prolonged 
incubation the phosphorylating mechanism becomes the pre- 
dominant regulatory mechanism (data not shown). 
If C2-ceramide specifically inhibits the phosphorylating 
mechanism, as the above results suggested, then one would 
expect no further modification of the maximal inhibitory effect 
of GF 109203X by ceramide. Indeed, in a similar experiment 
which is shown in Fig. 3A, 60/zM C2-ceramide failed to modify 
the inhibitory effect of 25 ~tM GF 109203X on PMA-induced 
PtdCho hydrolysis (data not shown). 
In summary, in NIH 3T3 fibroblasts C2-ceramide was found 
to preferentially inhibit PMA-induced PtdEtn hydrolysis. In 
addition, GF  109203X also preferentially inhibited PMA-in- 
duced PtdEtn hydrolysis when the incubation time was rela- 
tively short. In taking into account relevant data in the litera- 
ture, the best explanation we can presently offer for these phe- 
nomena is that C2-ceramide inhibits PLD activity by preventing 
a PMA-induced, and possibly PKC-c~-mediated, regulatory 
phosphorylation reaction. Experiments are underway in our 
laboratory to prove this possibility. 
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